Loading…
Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The agonists Zymosan, Trypanosoma cruzi GIPLs, Glycolipids (GIPLs)) lead to dimerization (= TLR2 / TLR6 heterodimer). The two adapter molecules, TIR domain-containing adapter protein (TIRAP) and Myeloid Differentiation Primary Response 88 (MYD88) are activated. Receptor-associated MyD88 recruits [Interleukin-1 receptor-associated kinase 4 (IR…